Pioneering breakthrough in the chemical synthesis of Interferon β-1a

July 10, 2013
Bachem building at the Bubendorf manufacturing site

Bubendorf/Basel, Switzerland and Kyoto, Japan, July 10, 2013 – GlyTech, Inc. (Kyoto, Japan) and Bachem AG (Bubendorf, Switzerland) informed that they have successfully co-developed a chemical synthesis of Interferon β-1a for industrial scale.
Download

Careers

At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.

View all jobs

Click here >>

Contact us

 

  • Please choose if you would like to receive additional email communications from Bachem:

  • Fields marked with an asterisk (*) are required

  • Hidden
    :
  • Hidden
  • This field is for validation purposes and should be left unchanged.